Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0005 EUR | -.--% | -.--% | -.--% |
Apr. 15 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
2023 | Canntab Therapeutics Limited Provide an Update on Product Delivery | CI |
Performance
3 years | -99.92% | ||
5 years | -99.90% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Alternative Medicine
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-.--% | -.--% | -.--% | -.--% | 142K | ||
+0.68% | +0.69% | +38.08% | +36.75% | 6.05B | ||
-0.46% | -2.13% | -16.43% | -39.56% | 4.45B | ||
-1.46% | -2.10% | -12.46% | -3.87% | 3.06B | ||
+1.21% | -1.06% | -0.21% | -16.24% | 3.04B | ||
-0.70% | +0.36% | -0.59% | -16.25% | 2.58B | ||
-2.99% | -1.20% | +34.54% | +46.25% | 1.79B | ||
-0.18% | +6.12% | +0.93% | -15.24% | 1.66B | ||
-0.33% | +0.21% | -10.63% | -30.89% | 1.63B | ||
+0.54% | 0.00% | -12.50% | -37.12% | 1.54B | ||
+0.69% | +8.30% | +37.15% | +0.69% | 1.42B | ||
+0.70% | +8.27% | +37.14% | -10.00% | 1.33B | ||
+0.62% | -4.43% | -20.22% | -20.81% | 1.24B | ||
-0.79% | -4.07% | +4.14% | -18.30% | 1.22B | ||
-2.74% | -0.93% | -15.71% | -35.62% | 1.01B | ||
-0.26% | +0.80% | -15.09% | -21.13% | 992M | ||
Average | -0.34% | +1.29% | +3.01% | -11.33% | ||
Weighted average by Cap. | -0.22% | +0.50% | +5.92% | -6.78% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2023 | -.--% | ||
2022 | -99.89% | ||
2021 | -3.69% | ||
2020 | +65.99% | ||
2019 | -34.38% | ||
2018 | -17.80% |
- Stock Market
- Equities
- PILL Stock
- TBF1 Stock
- Quotes Canntab Therapeutics Limited